UBS Maintains Neutral on Scotts Miracle Gro, Lowers Price Target to $61
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and lowers the price target from $62 to $61.
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and lowers the price target from $62 to $61.